QUASX
Price
$79.63
Change
+$1.05 (+1.34%)
Updated
Jun 2 closing price
Net Assets
2.99B
WCMNX
Price
$14.98
Change
+$0.18 (+1.22%)
Updated
Jun 2 closing price
Net Assets
52.45M
Interact to see
Advertisement

QUASX vs WCMNX

Header iconQUASX vs WCMNX Comparison
Open Charts QUASX vs WCMNXBanner chart's image
QUASX vs WCMNX Comparison Chart in %
View a ticker or compare two or three
VS
QUASX vs. WCMNX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QUASX is a Buy and WCMNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
QUASX has more cash in the bank: 2.99B vs. WCMNX (52.4M). QUASX (0.00) and WCMNX (0.00) have matching dividends . QUASX was incepted earlier than WCMNX: QUASX (57 years) vs WCMNX (7 years). WCMNX (2.04) is less costly to investors than QUASX (1.12). WCMNX is a more actively managed with annual turnover of: 89.00 vs. QUASX (72.00). WCMNX has a lower initial minimum investment than QUASX: WCMNX (1000) vs QUASX (2500). QUASX annual gain was more profitable for investors over the last year : 32.83 vs. WCMNX (25.42). QUASX return over 5 years is better than : 5.07 vs. WCMNX (-1.40).
QUASXWCMNXQUASX / WCMNX
Total Expense Ratio1.121.2490%
Annual Report Gross Expense Ratio1.122.0455%
Fund Existence57 years7 years-
Gain YTD18.0239.225195%
Front Load4%N/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets2.99B52.4M5,702%
Annual Yield % from dividends0.000.00-
Returns for 1 year32.8325.42129%
Returns for 3 years55.9431.21179%
Returns for 5 years5.07-1.40-362%
Returns for 10 years98.94N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IILGX32.710.13
+0.40%
Thrivent Global Stock S
BLDRX9.740.01
+0.10%
BlackRock Managed Income K
RYENX313.96N/A
N/A
Rydex Energy A
FPACX45.31N/A
N/A
FPA Crescent
NSCCX43.02N/A
N/A
Nuveen Small-Cap Value Opps C